Inventor · disambiguated record
Byong Ha Kang
Also filed as: KANG BYONG · KANG BYONG HA
5 granted patents·5 pending applications·10 citations·filing 2016–2025
74Inventor score
Files withASHER BIOTHERAPEUTICS INC4US HEALTH3MASSACHUSETTS INST TECHNOLOGY1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC1
Top patents by PatentIndex Score
10 records- 0190US12202886B2Neutralizing antibodies to GP120 and their useUS HEALTH·Filed 2022·Granted Jan 21, 2025·1 cites·11 claims
- 0290US11459389B2Monoclonal antibodies that bind human CD161MASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Oct 4, 2022·3 cites·16 claims
- 0390US10562960B2Neutralizing antibodies to gp120 and their useUS HEALTH·Filed 2016·Granted Feb 18, 2020·5 cites·41 claims
- 0487US12122827B2IL-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·1 cites·30 claims
- 0586US2025215068A1Neutralizing antibodies to gp120 and their useUS HEALTH·Filed 2024·Application pending·0 cites
- 0679US2025034242A1Il-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0775US12247072B2IL-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·0 cites·30 claims
- 0872US2021324053A1Neutralizing antibodies to gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2021·Application pending·0 cites
- 0969US2025197489A1Il-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1066US2020231658A1Neutralizing antibodies to gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Byong Ha Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →